Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_assertion type Assertion NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_head.
- NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_assertion description "[Correlation of sequencing and biochemical data reveals that using plasma guanidinoacetate (GAA) as a biomarker has 100% specificity for both AGAT and GAMT deficiencies, but AGAT deficiency has decreased sensitivity in this assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_provenance.
- NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_assertion evidence source_evidence_curated NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_provenance.
- NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_assertion SIO_000772 23660394 NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_provenance.
- NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_assertion wasDerivedFrom uniprot-20150221 NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_provenance.
- NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_assertion wasGeneratedBy ECO_0000218 NP2784.RAz4VYWy-FH6P2zgDdbe1AM3HDZx9uhx-r61WPGit-bvM130_provenance.